miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression. Ma C, He D, Tian P, Wang Y, et al. Proc Natl Acad Sci U S A 2022;119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma C, He D, Tian P, Wang Y, et al. miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression. Proc Natl Acad Sci U S A 2022;119.
PMID: 35105806